|
Volumn 119, Issue 1236, 2006, Pages
|
PHARMAC and erythropoietin for cancer patients.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERYTHROPOIETIN;
ANEMIA;
COST BENEFIT ANALYSIS;
DRUG CONTROL;
ECONOMICS;
EVIDENCE BASED MEDICINE;
HUMAN;
METHODOLOGY;
NEOPLASM;
NEW ZEALAND;
NOTE;
PUBLIC HEALTH;
TREATMENT OUTCOME;
ANEMIA;
COST-BENEFIT ANALYSIS;
DRUG AND NARCOTIC CONTROL;
ERYTHROPOIETIN;
EVIDENCE-BASED MEDICINE;
HUMANS;
NATIONAL HEALTH PROGRAMS;
NEOPLASMS;
NEW ZEALAND;
TREATMENT OUTCOME;
|
EID: 33746207807
PISSN: None
EISSN: 11758716
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (2)
|
References (0)
|